Drug Profile


Alternative Names: Candiplus; Clotrimazole/diclofenac sodium; ProF 001

Latest Information Update: 20 Jul 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator ProFem
  • Class Antifungals; Imidazoles; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action 14-alpha demethylase inhibitors; Cell membrane modulators; Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes - Candidiasis

Highest Development Phases

  • Phase II Candidiasis

Most Recent Events

  • 20 Jul 2017 Chemical structure information added
  • 03 Apr 2017 ProF 001 is available for licensing as of 03 Apr 2017.
  • 03 Apr 2017 ProFem has patent protection for ProF 001 (ProFem website, April 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top